Skip to main content
VA

Vaxdyn

Sevilla, Spain
Last funding
$12.8M
Series ASep 2026

Vaxdyn is a developer of multi-valent vaccines for preventing antibiotics-resistant infections.

Backed byEuropean Innovation Council FundCARB-XReig JofreBiovance CapitalArquimea Ingeniera

About Vaxdyn

How much funding has Vaxdyn raised?

Vaxdyn has raised $12.8M in total funding. The most recent round was Series A. The last funding was announced in September 2026.

Who are Vaxdyn's investors?

Vaxdyn's investors include European Innovation Council Fund, CARB-X, Reig Jofre, Biovance Capital, Arquimea Ingeniera.

Where is Vaxdyn headquartered?

Vaxdyn is headquartered in Sevilla, Spain.

What does Vaxdyn do?

Vaxdyn is a developer of multi-valent vaccines for preventing antibiotics-resistant infections.

What stage is Vaxdyn at?

Vaxdyn is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Vaxdyn — Funding & Investors." VCBacked, September 7, 2026, https://www.vcbacked.co/company/vaxdyn. Accessed November 13, 2026.
APA
VCBacked. (2026). Vaxdyn — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/vaxdyn
Wikipedia (cite web)
{{cite web |title=Vaxdyn — Funding & Investors |url=https://www.vcbacked.co/company/vaxdyn |website=VCBacked |access-date=November 13, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Vaxdyn? Request a listing update

Founder contacts
m***@vaxdyn.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →